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Abstract
This paper reports human immuno-deﬁciency virus (HIV) prevalence in the 2nd National Biological and Behavioral Surveillance Survey
(BBSS) among men who have sex with men (MSM) in 12 cities in Brazil using respondent-driven sampling (RDS).
Following formative research, RDS was applied in 12 cities in the 5 macroregions of Brazil between June and December 2016 to
recruit MSM for BBSS. The target sample size was 350 per city. Five to 6 seeds were initially selected to initiate recruitment and
coupons and interviews were managed online. On-site rapid testing was used for HIV screening, and conﬁrmed by a 2nd test.
Participants were weighted using Gile estimator. Data from all 12 cities were merged and analyzed with Stata 14.0 complex survey
data analysis tools in which each city was treated as its own strata. Missing data for those who did not test were imputed HIV+ if they
reported testing positive before and were taking antiretroviral therapy.
A total of 4176 men were recruited in the 12 cities. The average time to completion was 10.2 weeks. The longest chain length
varied from 8 to 21 waves. The sample size was achieved in all but 2 cities.
A total of 3958 of the 4176 respondents agreed to test for HIV (90.2%). For results without imputation, 17.5% (95%CI: 14.7–20.7)
of our sample was HIV positive. With imputation, 18.4% (95%CI: 15.4–21.7) were seropositive.
HIV prevalence increased beyond expectations from the results of the 2009 survey (12.1%; 95%CI: 10.0–14.5) to 18.4%; CI95%:
15.4 to 21.7 in 2016. This increase accompanies Brazil’s focus on the treatment to prevention strategy, and a decrease in support for
community-based organizations and community prevention programs.
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1. Introduction
Although global evidence shows an overall reduction in Acquired
Immune Deﬁciency Syndrome (AIDS) cases in many coun-
tries,[1,2] the human immuno-deﬁciency virus (HIV) epidemic
among men who have sex with men (MSM) in low-, middle-, and
high-income countries appears to be expanding.[3–7] MSM are at
high risk for HIV infection because of the syndemic of structural,
biological, and behavioral vulnerabilities that act together to
increase the chances of being infected.[3–5,8,9]
In Latin America, between 2000 and 2015, the number of new
HIV infections among adults has slowly risen. From2010 to 2015,
Brazil, a country with a history of an exemplary AIDS prevention
program, is now among those countries in Latin America (LA) and
Caribbean where HIV infection among adults has increased
(UNAIDS2016). Brazil has the largest population in the regionand
accounts for more than 41% of the total new infections occurring
among 7 countries: Argentina, the Bolivarian Republic of
Venezuela, Colombia, Cuba, Guatemala, Mexico, and Peru.[1]
Brazil presents great socioeconomic inequalities, and the AIDS
epidemic mirrors this inequality. From 2006 to 2015, AIDS rates
in the more developed South and Southeast regions of Brazil
demonstrated a reduction of 7.4% and 23.4%, respectively.
However, Porto Alegre, a state capital in the South region,
reported a very high rate of 74 AIDS cases/100,000 inhabitants
during the same period, twice the rate of the rest of the state and 4
times the Brazilian average. On the other hand, the North and
Northeast, the poorest regions in the country, showed a linear
increase in AIDS over the same period. AIDS rates increased from
14.9 to 24.0cases/100,000 inhabitants in North region, and 11.2
to 15.3cases/100,000 inhabitants in the Northeast, representing
a growth of 61.1% and 36.6%, respectively. Two states in these
regions, Pará and Maranhão, showed an increase of 91.5% and
82.9% in the incidence of AIDS cases, respectively.[10]
Over the past 10 years, in fact, there has been an increase in
new AIDS cases reported among men, especially those aged 15 to
19, 20 to 24, and 60 years of age and over. Focusing on an
alarming increased rate of new cases among young people, from
2006 to 2015 the rate among 15 to 19 year olds more than tripled
(2.4 to 6.7cases/100,000 inhabitants) and among those from 20
to 24, doubled (15.9–33.1cases/100,000). In the same period of
10 years, AIDS cases among MSM increased from 35.3% to
46.2% (31%) compared to all categories of AIDS cases reported
among men.[10]
In 2009, the Brazilian Ministry of Health conducted the ﬁrst
National HIV Biological and Behavioral Surveillance Survey
(BBSS) amongMSM, female sex workers (FSWs), and drug users
(DU) for HIV. The results showed HIV prevalence of 4.9%
among DU,[11] 5.8% among FSW,[12] and 12.1% among
MSM.[13] Compared to HIV prevalence in the general population
(estimated at 0.37%)[2] HIV prevalence among DU was 13 times
higher, among FSW was 16 times higher, and among MSM was
33 times higher. In 2016, the 2nd National BBSS was conducted
with MSM as we report here. FSW and, for the ﬁrst time,
transgender women were included in this BBSS and reported in
this journal.
The objective of this paper is to present the prevalence of HIV
infection among MSM in the 12 cities in Brazil that participated
in the BBSS in 2016, the main outcome of this survey.
2. Material and methods
The study used respondent-driven sampling (RDS) method to
recruit participants and analyze results. RDS was chosen as the
most appropriate method among available alternatives for
reasons that included the large and mostly hidden social
networks of MSM, and for comparison to Brazil’s ﬁrst HIV
BBSS in 2006.[14] Eligibility was limited to men 18 years of age or
older reporting oral or anal sex with another man in the last 12
months, and residing, working, or studying in one of the 12 cities.
The surveys were conducted from June to December 2016 in 12
Brazilian State capitals in the 5 Regions of Brazil. These were:
Manaus, Belém, (North Region); Fortaleza, Recife, Salvador,
(Northeast Region); Brasília, Campo Grande (Central West
Region); Belo Horizonte, Rio de Janeiro, and São Paulo
(Southeast Region); and Curitiba and Porto Alegre (South
Region) (Fig. 1).
Formative research was conducted among 184 MSM between
December 2015 and March 2016, to explore sex and gender
identities, changes in HIV-related behaviors, organization of
the MSM communities, and siting of the study ofﬁce, incentive
level, willingness to participate and provide a biological
specimen, potential bottlenecks, and other operational issues.
The BBSS was initiated with 5 to 6 seeds in each site selected to
represent age and socioeconomic diversity within the MSM
community. Only 2 sites added additional seeds when they felt
recruitment was slowing (Table 1). Three coupons were
distributed to each respondent to recruit others to the study.
Each participant received a primary incentive of R$25 (25 Reais,
the Brazilian currency or about US$7) and a secondary incentive
of R$25 for each person recruited who completed the survey.
Coupons and study IDs were managed with an on-line coupon
generator developed as part of the data entry program. The social
network question cascade is summarized in the following
question: “How many men do you know, who also know
you, who have had sex with other men (oral or anal) in the last
12 months, who live, study, or work in (municipality), are 18
years old or older, and that you encountered or spoke with in the
last 2 months? Of these (repeat the number provided by the
participant) how many would you invite to participate in this
study?” The BBSS used Computer Assisted Personal Interview
and all results were encrypted and uploaded to a password
protected project database. Seeds were included in the sample for
analysis.
Following counseling, 2 tubes of venous blood were drawn.
For HIV, blood was ﬁrst tested with a rapid test for Anti-HIV
antibodies (Alere/Bioeasy). If positive, the bloodwas tested with a
second rapid test (Abon). Two positive results fulﬁlled Ministry
criteria for reporting HIV positive serostatus. Respondents who
tested positive for HIV were counseled and immediately referred
to HIV/AIDS care centers in each of the 12 cities.
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3. Analysis
HIV prevalence was the result of the constructed variable of
the 2 positive rapid HIV tests, the criterion used by the Ministry
of Health. An additional HIV prevalence was estimated by
adding individuals who refused to test, reported positive HIV
status, and who were taking antiretrovirals. Gile successive
sampling estimator[15] was used to produce weighted estimates
of both prevalence rates using RDS analyst.[16] To calculate a
single nation-wide HIV prevalence, data from the 12 cities
were merged and analyzed with Stata 14.0 complex survey
data analysis tools in which each city was treated as its own
strata.
Figure 1. States and cities where RDS among MSM was conducted in 2016, Brazil. MSM=men who have sex with men, RDS= respondent-driven sampling.
Table 1
2016 RDS survey duration, seeds and longest wave, and eligibility by site (sample size n=4176).
Manaus Belém Fortaleza Recife Salvador Campo Grande Brasília Belo Horizonte São Paulo Rio de janeiro Curitiba Porto Alegre
Start (2016) 07/12 07/12 07/11 07/12 07/26 07/14 09/13 06/22 06/23 08/01 07/21 08/22
Total weeks 7.5 5.9 9.6 6.9 9.2 8.7 11.3 7.7 9.7 17.6 13.6 14.6
Total seeds 7 6 5 7 5 6 5 6 6 6 5 6
Longest Waves 12 8 10 18 14 15 13 14 13 15 21 14
Ineligible 19 4 1 4 4 2 4 25 9 27 22 3
Reason:
<18 y 3 0 0 1 1 2 1 2 0 1 4 1
Not local 1 2 0 0 0 0 0 1 5 1 3 1
No sex 12 mo 13 2 0 2 3 0 0 5 3 22 12 0
Incapable 0 0 0 1 0 0 1 0 0 0 0 0
Total eligible 351 350 356 359 350 352 361 350 353 325 352 338
Sample size 351 350 353 349 350 352 359 350 351 325 348 338
Network (median–
min–max)
6 (1–200) 5 (1–1.000) 4 (1–687) 8 (1–250) 10 (1–300) 10 (1–5.000) 10 (1–300) 11 (1–1.000) 10 (1–2.500) 10 (1–2.500) 7 (1–380) 10 (1–270)
RDS= respondent driven sampling.
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4. Ethical considerations
The overall study was approved by the Committee on Research
Ethics of the Federal University of Ceará, accredited by the
National Commission on Research (#1.024.053(23/06/2015)).
All respondents signed a consent form to participate in the
interview and separately consented for each test that was offered.
5. Results
Data were collected from June 23, 2016 in Belo Horizonte to
December 2, 2016, in Rio de Janeiro and Porto Alegre (Table 1).
Average time to completion was 10.2 weeks, with Belém ﬁnishing
in 6 weeks and Rio de Janeiro requiring 17.6 weeks. Median
network size of members whomight be recruited varied from 4 to
10. Longest chain length varied from 8 waves in Belém to 21
waves in Curitiba. There were relatively few ineligible partic-
ipants, ranging from 1 in Fortaleza to 27 in Rio de Janeiro. Rio de
Janeiro and Porto Alegre did not achieve the sample size of 350
designated by the Ministry of Health.
Our sample was young (58.3%<25; 95%CI: 54.6–62.0), a
majority of mixed ethnicity (42.0%; 95%CI: 38.5–45.6), and
relatively well educated, with 59.3% having completed high
school (95%CI: 55.7–62.8) (Table 2). Using the standard
socioeconomic strata (A–E) developed by the Brazilian Associa-
tion of Research Organizations,[17] our sample was majority
middle (C) (43.0%; 95%CI: 39.4–46.7) and lower (D, E) strata
(16.2%; 95% CI: 13.8–19.0). Single men constituted 83.0% of
the sample (95% CI: 80.1–85.6).
A total of 3958 of the 4176 respondents agreed to test for HIV
(90.2%) (95%CI: 87.3–92.4) (Table 3). For results without
imputation as described above, 17.5% (95%CI: 14.7–20.7) of
our sample were HIV positive. With imputation, 18.4% (95%CI:
15.4–21.7) were seropositive (Table 4). There was important
variation among cities, with Brasília reporting the lowest
prevalence (5.8%; 95%CI: 3.5–9.6) and São Paulo the highest
(24.8%; 95%CI: 18.5–32.4), maintaining these positions with
and without imputation (Table 4).
6. Discussion
This report joins Brazil to a growing number of countries
demonstrating high levels of HIV prevalence among MSM.[3,18]
These reports challenge the initial optimism for test and treat
strategies for controlling and ultimately eliminating HIV.[19–22]
Although successful treatment will increase prevalence there is
evidence of increasing incidence and important gaps in preven-
tion, including a fall-off in the promotion and use of condoms
and other preventive behaviors.[1] Available data on HIV
prevalence and incidence from low, middle, and high-income
countries suggest that the HIV epidemics among MSM are
increasing due to stigma and discrimination, sexual behavior, and
issues with adherence and care-seeking.[23] From its onset, the
HIV epidemic in Brazil has been a concentrated epidemic, with
stable prevalence rates around 0.37%2 for the general popula-
tion, and above 5% prevalence rates among MSM, FSWs, and
illicit DU. Structural barriers, conservative social and religious
movements in government and insufﬁcient allocation of funds
from local governments, may have contributed to the deﬁcits in
primary prevention programs reported in Brazil.[1]
Our study shows higher levels of HIV prevalence among the
MSM in the 12 cities (18.4%; CI95%: 15.4–21.7) we studied
compared to the BBSS we conducted in 2009 in 10 cities (12.1%;
95%CI: 10.0–14.5) suggesting a potential increase in HIV
incidence. In our discussion, we explore several potential reasons
for rising seroprevalence.
Accounting for reasons for nation-wide changes in HIV
prevalence across time is not a simple task.[24] The causes of
changes in the HIV epidemic are inherently multidimensional,
involving environments of vulnerability and risk, stigma and
discrimination for key populations, and changing behaviors,
policies, and programs. During the period between our 2 surveys
there have been major new strategies to address HIV/AIDS
programs and important changes in the institutional, social, and
political context in Brazil. Many of these changes – positive and
negative – are well documented in Malta and Beyrer.[25]
In addition to changes in these contexts, the changes in sexual
behavior among the youth in our sample, shown in accompa-
nying paper in this journal, is also concerning. In addition, the
formative research for our study uncovered a catchphrase used by
youth: “AIDS já não me assusta mais” (AIDS does not scare me
Table 2
Summary of socioeconomic and demographic characteristics of
MSM participants in 12 cities, Brazil 2016.
95% CI
% L U
Age
<25 y 58.3 54.6 62.0
>=25 y 41.7 38.0 45.4
Race
White 31.8 28.5 35.3
Black 21.8 19.0 25.0
Asian 2.4 1.6 3.7
Mulato/mixed or brown 42.0 38.5 45.6
Indigenous/native 1.9 1.1 3.3
Years of school
4 y 3.5 2.1 5.6
5–8 y 9.4 7.6 11.6
9–11 y 16.8 14.3 19.5
High school/incomplete college 59.3 55.7 62.8
College graduate 11.1 9.0 13.6
Socioeconomic Strata (ABEP)
∗
A/B (higher) 40.7 37.3 44.2
C (middle) 43.0 39.4 46.7
D/E (lower) 16.2 13.8 19.0
Civil status
Single 83.0 80.1 85.6
Married 3.6 2.5 5.2
Same sex stable union 10.2 8.1 12.7
Stable union with woman 1.0 0.5 2.0
Separate/divorced 2.0 1.4 3.0
Widower 0.3 0.1 0.7
CI= conﬁdence interval, MSM=men who have sex with men.
∗
ABEP Brazilian Association of Research Organizations.
Table 3
Tested for HIV in the study.
HIV test n/N
∗
%†
95%CI†
LL UL
No 218/4176 9.8 7.6 12.7
Yes 3958/4176 90.2 87.3 92.4
CI=conﬁdence interval, HIV=human immuno-deﬁciency virus, LL= lower limit, UL=upper limit.
∗
Not weighted.
†Weighted.
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anymore).[26] Understanding this comment requires understand-
ing the new scenario for AIDS created by antiretrovirals and the
“treatment to prevention” initiatives[27,28] such as early treat-
ment and preexposure prophylaxis. These initiatives have
resulted in a medicalized approach that treats HIV infection as
a lifelong chronic condition.[29] In parallel, NGOs that addressed
MSM and AIDS prevention have been defunded, removing
spaces for community organizing around prevention and testing,
and for generating solidarity among the MSM communi-
ties.[30,31] Growing support in the Brazilian government for
the “Bullets, Beef, and Bible” caucus, in the most conservative
congress in the Brazil democratic era, has led to a regressive
gender and sexuality agenda and reduced support for programs
that focus on MSM needs.[25,30,32] In fact, there have been major
budget cuts or dismantling of programs in research, prevention,
and treatment throughout the health sector.[33]
Our 2016 sample is younger than the 2009 sample.[13]
Although HIV prevalence increases with increasing age due
to cumulative incidence and improved survival, the much
higher prevalence in 2016 is particularly notable. The trend
toward rising new infections among youth is not isolated to
Brazil. The US Centers for Disease Control report that in the
US youth aged 13 to 24 account for 20% of all new HIV
diagnoses, 81% of those occurring among self-reporting gay
and bisexual males. Youth presents a special problem, reports
CDC: they are the least likely to test or to use a condom, are
more likely to drink or use drugs during sex, and have 4 or
more partners during their incipient sexual careers.[34] Other
studies conﬁrm these differences between younger and older
MSM. Analyzing from a generational perspective,Méthy et al[35]
report for France that the younger generation of MSM are more
likely to have their ﬁrst sex with a man compared to the older
generation of MSM, who were youth in the 1980s. Reports of
oral and anal sex, and frequency of sex were lower for older
generations of MSM, but are higher among the younger
generation today. Interestingly, Wall et al note for the US
similarities in this increased sexual frequency in both young
MSM and heterosexuals.[36]
6.1. Limitations
This is a repeated sample among MSM in Brazil using RDS.
Limitations of RDS have been well documented.[15,37,38] A recent
publication has also criticized the reliability of RDSwhen repeated
in the same population in a relatively short period of time.[39]
Because the sample selected throughRDS is a product of a series of
both theoretical assumptions and operational issues, such as seed
selection, logistics, and control of “masking,” two consecutive
samples could differ substantially. Khatib et al[39] in discussing
reproducibility refer to an earlier study inZanzibar.[40] In the latter
study non-MSM IDUs masking as MSM entered the study and
drove up the seroprevalence rate. For this reason, formative
research and monitoring,[41] applying a large design effect,[42]
adherence to STrengthening the Reporting of OBservational
studies in Epidemiology (STROBE) RDS guidelines,[43] and RDS
diagnostics are proposed.[37] Until better methods are available,
RDS will continue to be used to provide population estimates of
hard to reach populations in the HIV epidemic. Even though our
sample is different from the one in 2009, our ﬁndings move in the
same direction as other sources of information.[2,44,45]
7. Conclusions
We take the opportunity in this paper to not just focus on our
numbers, but advocate for a response. Our ﬁndings present a
serious challenge to policy makers: how are we to address the
increasing epidemic among MSM in Brazil? Our results argue
for an invigorated prevention effort combining innovative
approaches such as engaging communities in developing
solutions and involving communities themselves in research,
publication, and enhanced advocacy.[46] Such strategies are part
of a new sustainable development agenda, together with
investment in science, innovative solutions, national and local
leadership, and strong political commitment to achieve these
targets. Parker terms this approach “prevention literacy” to
complement treatment literacy, building on the strategy that used
NGOs and community participation to promote prevention.[47]
Preventing AIDS makes sense on so many levels, but for
Table 4
HIV test in MSM with and without imputation by city.
HIV HIV with imputation
∗
Positive Negative Positive Negative
95%CI‡ 95%CI‡ n† 95%CI‡
City n† %‡ LL UL %‡ LL UL %‡ 95%CI‡ LL UL %‡ LL UL
Manaus 351 15.1 10.5 21,1 84.9 78.9 89.5 351 15.1 10.5 21.1 84.9 78.9 89.5
Belém 295 18.2 13.0 24.9 81.8 75.1 87.0 300 19.2 13.8 26.0 80.8 74.0 86.2
Fortaleza 337 10.0 6.4 15.2 90.0 84.8 93.6 337 10.0 6.4 15.2 90.0 84.8 93.6
Recife 345 21.0 15.5 27.7 79.0 72.3 84.5 346 21.5 16.0 28.3 78.5 71.7 84.0
Salvador 337 8.6 5.0 14.4 91.4 85.6 95.0 337 8.6 5.0 14.4 91.4 85.6 95.0
Campo Grande 351 9.5 5.0 17.1 90.5 82.9 95.0 351 9.5 5.0 17.1 90.5 82.9 95.0
Brasília 355 5.8 3.5 9.6 94.2 90.4 96.5 355 5.8 3.5 9.6 94.2 90.4 96.5
Belo Horizonte 326 14.3 8.9 22.3 85.7 77.7 91.1 327 14.5 9.0 22.4 85.5 77.6 91.0
São Paulo 338 23.0 17.1 30.3 77.0 69.7 82.9 341 24.8 18.5 32.4 75.2 67.6 81.5
Rio de Janeiro 254 15.2 9.1 24.3 84.8 75.7 90.9 256 15.3 9.2 24.4 84.7 75.6 90.8
Curitiba 331 19.9 14.2 27.2 80.1 72.8 85.8 332 20.2 14.4 27.4 79.8 72.6 85.6
Porto Alegre 316 9.8 5.9 15.8 90.2 84.2 94.1 319 10.5 6.5 16.5 89.5 83.5 93.5
Total 3936 17.5 14.7 20.7 82.5 79.3 85.3 3952 18.4 15.4 21.7 81.6 78.3 84.6
CI= conﬁdence interval, HIV=human immuno-deﬁciency virus, LL= lower limit, UL=upper limit.
∗
Tested in the study plus individuals reporting HIV+ status and on antiretrovirals.
† Not weighted.
‡Weighted.
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governments actively shrinking health budgets, reducing trans-
mission makes ultimate sense.
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